Eric Karran
- Physiology top 0.1%
- Alzheimer's disease research and treatments 39
- Biological Psychiatry top 0.5%
- Neurology top 0.2%
- Neuroinflammation and Neurodegeneration Mechanisms 8
- Pharmacology top 0.2%
- Cholinesterase and Neurodegenerative Diseases 13
-
- Nuclear Receptors and Signaling 6
-
- Computational Drug Discovery Methods 11
-
- Protease and Inhibitor Mechanisms 9
-
- Peptidase Inhibition and Analysis 5
-
- Cellular transport and secretion 5
- Co-authors
- Bart De StrooperMarc MerckenIryna BenilovaNigel M. HooperAnthony J. TurnerGary ChristieRalph HydeViktor Lakics
- Journals
- Biochemical Journal (6 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Journal of Biological Chemistry (4 papers)
- Partner nations
- United KingdomUnited StatesBelgium
In The Last Decade
Eric Karran
71 papers receiving 10.9k citations
Hit Papers
Peers
Comparison fields: 5 of 150
- Physiology 5.7k
- Biological Psychiatry 542
- Neurology 1.7k
- Pharmacology 2.0k
- Cellular and Molecular Neuroscience 1.4k
Countries citing papers authored by Eric Karran
This map shows the geographic impact of Eric Karran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Karran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Karran more than expected).
Fields of papers citing papers by Eric Karran
This network shows the impact of papers produced by Eric Karran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Karran. The network helps show where Eric Karran may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eric Karran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 31 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 24 | |
| 5 | 2021 | 17 | |
| 6 | 2021 | 16 | |
| 7 | 2020 | 10 | |
| 8 | The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaquesbreakdown → | 2019 | 539 |
| 9 | The Cellular Phase of Alzheimer’s Diseasebreakdown → | 2016 | 1280 |
| 10 | 2015 | 1 | |
| 11 | The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothesbreakdown → | 2012 | 1611 |
| 12 | The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeuticsbreakdown → | 2011 | 1707 |
| 13 | Translational sciences-turning drug-like molecules into medicines. | 2006 | 2 |
| 14 | 2000 | 219 | |
| 15 | 1999 | 52 | |
| 16 | 1998 | 43 | |
| 17 | 1996 | 34 | |
| 18 | 1996 | 26 | |
| 19 | 1995 | 2 | |
| 20 | 1993 | 32 |
About Eric Karran
Eric Karran is a scholar working on Physiology, Neurology and Pharmacology, having authored 74 papers that have together received 11.1k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (39 papers), Cholinesterase and Neurodegenerative Diseases (13 papers), Computational Drug Discovery Methods (11 papers), Protease and Inhibitor Mechanisms (9 papers), Neuroinflammation and Neurodegeneration Mechanisms (8 papers), Nuclear Receptors and Signaling (6 papers), Peptidase Inhibition and Analysis (5 papers) and Cellular transport and secretion (5 papers). The work is most often cited by research in Physiology (5.7k citations), Biological Psychiatry (542 citations) and Neurology (1.7k citations). Eric Karran has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Bart De Strooper, Marc Mercken, Iryna Benilova, Nigel M. Hooper, Anthony J. Turner, Gary Christie, Ralph Hyde, Viktor Lakics, Frank Boess and John Hardy. Their work appears in journals such as Biochemical Journal, Bioorganic & Medicinal Chemistry Letters, Journal of Biological Chemistry, Alzheimer s & Dementia and Biochemical Society Transactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.